← USPTO Patent Grants

Antibodies having specificity to HER4 and uses thereof

Grant US12577324B2 Kind: B2 Mar 17, 2026

Assignee

INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)

Inventors

Andre Pelegrin, Pierre Martineau, Thierry Chardes, Romain Lanotte

Abstract

The present invention relates to antibodies having specificity to HER4 and uses thereof, which are able to induce biased 4ICD routing/signaling. The inventors have isolated by antibody phage display three fully human anti-HER4 single-chain variable antibody fragment (scFv), selected on human HER4 extracellular domain, referred as C6 mAb, D5 mAb and F4 mAb and one fully human anti-HER4 scFv named H2 mAb, selected on NRG 1β1-stimulated EGFR/HER4 JMaCYT1-transfected NIH3T3 cells. In particular, the present invention relates to an isolated anti-HER4 antibody, wherein said antibody binds to an epitope of the HER4 protein.

CPC Classifications

A61K 47/6817 A61K 47/6869 A61K 2039/505 A61P 15/00 A61P 35/00 C07K 16/32 C07K 2317/21 C07K 2317/24 C07K 2317/565 C07K 2317/622 C07K 2317/73 C07K 2317/75 C07K 2317/76

Filing Date

2020-12-08

Application No.

17783182

Claims

16